Bill Duncan

I'm not so sure. Here is the axiom for `drug product`: ``` 'material entity' and ('is bearer of' some 'clinical drug role') and (has_proper_part some ('scattered molecular aggregate' and ('is...

@sivaramarabandi your proposal makes sense, however, this is not what is in `cido`. Currently, these are the **equivalence** axioms that define `drug product`: ``` 'material entity' and ('is bearer of'...

@linikujp `application` comes from CHEBI: http://purl.obolibrary.org/obo/CHEBI_33232 It is a kind of CHEBI:role, which (from I can tell) more closely aligns with a BFO: disposition.

@cmungall Thanks for pointing out the need for more information. Going back to your original point (I think) about adding metadata to the "edge" `treatment for some COVID-19 disease process`....

Thanks! How would you get it to stream results w/o hitting the `;`. After some digging, I found that you could enter rules using the `user` pseudo file (not sure...

In the [setup.py on nmdc-schema](https://github.com/microbiomedata/nmdc-schema/blob/ca2f6e0ebef7699f554a5dc2abae4e994ce61765/setup.py#L22) you will see the `validate-nmdc-json` and `nmdc-version` entry points. This allows to run the associated python files from any directory just like other command line...

@bfurner Ah yes ... you are right Biolink does have an `entity` class. I like the clean separation between named things and associations. This might benefit the ccdh model.

@bfurner Not sure I follow what you mean by "profiling". Do you have link to a design pattern? From what I could tell there are a common set of attributes...

@bfurner I just saw that there is a class [Observation](https://cancerdhc.github.io/ccdhmodel/v1.1/Observation/). Sorry ... However, the documentation does not show any linkage between a specific kind of observation (e.g., [alcohol exposure observation](https://cancerdhc.github.io/ccdhmodel/v1.1/AlcoholExposureObservation/))...

Thanks @alanruttenberg !